Pasar al contenido principal

Idioma del documento

Encontrados 4449804 resultado(s)
Encontradas 44499 página(s)

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Alba, E, Lluch, A, Ribelles, N, Anton-Torres, A, Sanchez-Rovira, P, Albanell, J, Calvo, L, García-Asenjo, JAL, Palacios, J, Chacon, JI, Ruiz, A, De la Haba-Rodriguez, J, Segui-Palmer, MA, Cirauqui, B, Margeli, M, Plazaola, A, Barnadas, A, Casas, M, Caballero, R, Carrasco, E, Rojo, F

Background. In the neoadjuvant setting, changes in the proliferation marker Ki67 are associated with primary endocrine treatment efficacy, but its value as a predictor of response to chemotherapy is still controversial. Patients and Methods. We analyzed 262 patients with centralized basal Ki67 immunohistochemical evaluation derived from 4 GEICAM(Spanish Breast Cancer Group) clinical trials of neoadjuvant chemotherapy for breast cancer. The objective was to identify the optimal threshold for...



Hyperinsulinemic Hypoglycemia after Bariatric Surgery: Diagnosis and Management Experience from a Spanish Multicenter Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Vilarrasa, N, Goday, A, Rubio, MA, Caixàs, A, Pellitero, S, Ciudin, A, Calañas, A, Botella, JI, Bretón, I, Morales, MJ, Díaz-Fernández, MJ, García-Luna, PP, Lecube, A

Background: Severe postprandial hypoglycemia after bariatric surgery is a rare but invalidating complication. Our aim was to describe the different tests performed for its diagnosis and their outcomes as well as the response to the prescribed pharmacological and surgical treatments. Methods: Multicenter, retrospective systematic review of cases with recurrent severe postprandial hypoglycemia. Results: Over 11 years of follow-up, 22 patients were identified. The test most used to provoke...



Coping strategies and postpartum depressive symptoms: A structural equation modelling approach

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Gutiérrez-Zotes, A, Labad, J, Martín-Santos, R, García-Esteve, L, Gelabert, E, Jover, M, Guillamat, R, Mayoral, F, Gornemann, I, Canellas, F, Gratacós, M, Guitart, M, Roca, M, Costas, J, Ivorra, JL, Navinés, R, de Diego-Otero, Y, Vilella, E, Sanjuan, J

Background: Variables such as the mother's personality, social support, coping strategies and stressful events have been described as risk factors for postpartum depression. Structural Equation Modelling (SEM) analysis was used to examine whether neuroticism, perceived social support, perceived life events, and coping strategies are associated with postpartum depressive symptoms at the 8th and 32nd weeks. Methods: A total of 1626 pregnant women participated in a longitudinal study....



GEITDAH consensus on conduct disorders in children and adolescents

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Sasot-Llevadot, J, Ibáñez-Bordas, RM, Soto-López, A, Montañés-Rada, F, Gastaminza-Pérez, X, Alda-Díez, JA, Cantó-Díez, T, Catalá, MA, Ferrin-Erdozáin, M, García-Giral, M, Graell-Bernal, M, Granada-Jiménez, O, Herreros-Rodríguez, O, Mardomingo-Sanz, MJ, Mojarro-Práxedes, D, Morey-Canyelles, J, Ortiz-Guerra, J, Pàmies-Massana, M, Rey-Sánchez, F, Romera-Torrens, M, Rubio-Morell, B, Ruiz-Lázaro, PM, Ruiz-Sanz, F

In this paper, the Special Interest Group on Attention Deficit Hyperactivity Disorder (GEITDAH, from its name in Spanish) presents a consensus reached by experts from all over Spain on conduct disorders in children and adolescents. Following the initial work by the team at the Pedopsychiatry Unit at the Quiron-Teknon Hospital in Barcelona, agreements have been reached on a number of basic aspects that could be the starting point for future consensuses. A top priority aim of the work was also to...



Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Piqué, N, Ponce, M, Garrigues, V, Rodrigo, L, Calvo, F, de Argila, CM, Borda, F, Naranjo, A, Alcedo, J, Soria, MJ, Rey, E, Bujanda, L, Gisbert, JP, Suarez, D, Calvet, X, Ponce, J

Background The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. Objective The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. Methods A prospective, observational, cross-sectional, multicenter study (PRESS study) was conducted among 31 gastrointestinal endoscopy units throughout Spain. A total of 1361 patients undergoing upper gastrointestinal...



Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Turnes, J, Díaz, R, Hernandez-Guerra, M, Gómez, M, Castells, L, Bustamante, J, Espinosa, MD, Fernández-Castroagudín, J, Serrano, T, Rendón, P, Andrade, R, Salgado, M, Arenas, J, Vergara, M, Sala, M, Polo, BA, Granizo, IM, Gonzálvez, ML, Viudez, A

Introduction: GIDEON is a non-interventional, prospective, international study that evaluated the safety of sorafenib in patients with unresectable hepatocellular carcinoma (HCC) in daily clinical practice, including Child-Pugh B patients. Objectives: To analyze data collected in Spain on the safety and efficacy of sorafenib and treatment patterns. Methods: Data were collected during follow-up on demographic and disease characteristics, the initial dose used, treatment-emergent adverse events...



Registry of the Spanish Network for Systemic Sclerosis <i>Survival</i>, <i>Prognostic Factors</i>, <i>and Causes of Death</i>

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Simeón-Aznar, CP, Fonollosa-Plá, V, Tolosa-Vilella, C, Espinosa-Garriga, G, Campillo-Grau, M, Ramos-Casals, M, García-Hernández, FJ, Castillo-Palma, MJ, Sánchez-Román, J, Callejas-Rubio, JL, Ortego-Centeno, N, Egurbide-Arberas, MV, Trapiellla-Martínez, L, Caminal-Montero, L, Sáez-Comet, L, Velilla-Marco, J, Camps-García, MT, de Ramón-Garrido, E, Esteban-Marcos, EM, Pallarés-Ferreres, L, Navarrete-Navarrete, N, Vargas-Hitos, JA, de la Torre, RG, Salvador-Cervello, G, Rios-Blanco, JJ, Vilardell-Tarrés, M

Systemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability in disease progression and prognosis. In the present study, we assess survival, causes of death, and risk factors of mortality in a large series of Spanish SSc patients. Consecutive SSc patients fulfilling criteria of the classification by LeRoy were recruited in the survey. Kaplan-Meier and Cox proportional-hazards models were used to analyze survival and to identify predictors of mortality. Among...



Methicillin-resistant <i>Staphylococcus</i> <i>aureus</i> (MRSA) catheter-related bacteraemia in haemodialysis patients

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Cuervo, G, Camoez, M, Shaw, E, Dominguez, MA, Gasch, O, Padilla, B, Pintado, V, Almirante, B, Molina, J, López-Medrano, F, de Gopegui, ER, Martinez, JA, Bereciartua, E, Rodriguez-Lopez, F, Fernandez-Mazarrasa, C, Goenaga, MA, Benito, N, Rodriguez-Baño, J, Espejo, E, Pujol, M

Background: The aim of the study was to determine clinical and microbiological differences between patients with methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia (CRB) undergoing or not undergoing haemodialysis, and to compare outcomes. Methods: Prospective multicentre study conducted at 21 Spanish hospitals of patients with MRSA bacteraemia diagnosed between June 2008 and December 2009. Patients with MRSA-CRB were selected. Data of patients on haemodialysis (HD...



<i>POLE</i> and <i>POLD1</i> screening in 155 patients with multiple polyps and early-onset colorectal cancer

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Esteban-Jurado, C, Giménez-Zaragoza, D, Muñoz, J, Franch-Expósito, S, Alvarez-Barona, M, Ocaña, T, Cuatrecasas, M, Carballal, S, López-Cerón, M, Marti-Solano, M, Díaz-Gay, M, van Wezel, T, Castells, A, Bujanda, L, Balmaña, J, Gonzalo, V, Llort, G, Ruiz-Ponte, C, Cubiella, J, Balaguer, F, Aligué, R, Castellví-Bel, S

Germline mutations in POLE and POLD1 have been shown to cause predisposition to colorectal multiple polyposis and a wide range of neoplasms, early-onset colorectal cancer being the most prevalent. In order to find additional mutations affecting the proofreading activity of these polymerases, we sequenced its exonuclease domain in 155 patients with multiple polyps or an early-onset colorectal cancer phenotype without alterations in the known hereditary colorectal cancer genes. Interestingly,...



Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Martín, M, Chacón, JI, Antón, A, Plazaola, A, García-Martínez, E, Seguí, MA, Sánchez-Rovira, P, Palacios, J, Calvo, L, Esteban, C, Espinosa, E, Barnadas, A, Batista, N, Guerrero, A, Muñoz, M, Romio, E, Rodríguez-Martín, C, Caballero, R, Casas, MI, Rojo, F, Carrasco, E, Antolin, S

Background. Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel) is an alternative to standard taxanes for breast cancer (BC) treatment. We evaluated nab-Paclitaxel efficacy as neoadjuvant treatment for early estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) disease. Materials and Methods. Women with ER1, HER2-, stage II-III BC were treated preoperatively with four cycles of weekly nab-Paclitaxel (150 mg/m(2)), 3 weeks on and 1 week off. We...



Oral Immunotherapy for Food Allergy: A Spanish Guideline. Egg and Milk Immunotherapy Spanish Guide (ITEMS GUIDE). Part II: Maintenance Phase of Cow Milk (CM) and Egg Oral Immunotherapy (OIT), Special Treatment Dosing Schedules. Models of Dosing Schedules of OIT With CM and Egg

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Martorell, A, Alonso, E, Echeverría, L, Escudero, C, García-Rodríguez, R, Blasco, C, Bone, J, Borja-Segade, J, Bracamonte, T, Claver, A, Corzo, JL, De la Hoz, B, Del Olmo, R, Dominguez, O, Fuentes-Aparicio, V, Guallar, I, Larramona, H, Martín-Muñoz, F, Matheu, V, Michavila, A, Ojeda, I, Ojeda, P, Piquer, M, Poza, P, Reche, M, del Río, R, Rodríguez, M, Ruano, F, Sánchez-García, S, Terrados, S, Valdesoiro, L, Vazquez-Ortiz, M

Introduction: Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. Methods: A review was made of studies published between 1984 and June 2016, doctoral...



Oral Immunotherapy for Food Allergy: A Spanish Guideline. Immunotherapy Egg and Milk Spanish Guide (ITEMS Guide). Part I: Cow Milk and Egg Oral. Immunotherapy: Introduction, Methodology, Rationale, Current State, Indications, Contraindications, and Oral Immunotherapy Build-up Phase

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Martorell, A, Alonso, E, Echeverría, L, Escudero, C, García-Rodríguez, R, Blasco, C, Bone, J, Borja-Segade, J, Bracamonte, T, Claver, A, Corzo, JL, De la Hoz, B, Del Olmo, R, Dominguez, O, Fuentes-Aparicio, V, Guallar, I, Larramona, H, Martín-Muñoz, F, Matheu, V, Michavila, A, Ojeda, I, Ojeda, P, Piquer, M, Poza, P, Reche, M, del Rio, PR, Rodríguez, M, Ruano, F, Sánchez-García, S, Terrados, S, Valdesoiro, L, Vazquez-Ortiz, M

Introduction: Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. Methods: A review was made of studies published between 1984 and June 2016, doctoral...



On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Carmona-Bayonas, A, Jiménez-Fonseca, P, Lorenzo, MLS, Ramchandani, A, Martínez, EA, Custodio, A, Garrido, M, Echavarría, I, Cano, JM, Barreto, JEL, García, TG, Manceñido, FA, Lacalle, A, Cardona, MF, Mangas, M, Visa, L, Buxó, E, Azkarate, A, Díaz-Serrano, A, Montes, AF, Rivera, F

Background: There is currently no consensus regarding first-line chemotherapy for patients with advanced gastric cancer (AGC) who are ineligible to receive trastuzumab. The objective of this study was to evaluate the efficacy and tolerance of triplets versus doublets by analyzing a national gastric cancer registry. Patients and Method: Patients with AGC treated with polychemotherapy without associating trastuzumab were included from 2008 through 2016. The effect of triplets versus doublets was...



Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Laguno, M, Von Wichmann, MA, Van den Eynde, E, Navarro, J, Cifuentes, C, Murillas, J, Veloso, S, Martinez-Rebollar, M, Guardiola, JM, Jou, A, Gomez-Sirvent, JL, Cervantes, M, Pineda, JA, Lopez-Calvo, S, Carrero, A, Montes, ML, Deig, E, Tapiz, A, Ruiz-Mesa, JD, Cruceta, A, de Lazzari, E, Mallolas, J

Introduction: Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC + pegylated interferon-alpha 2a/ribavirin (PEG-IFN/RBV) in the retreatment of HIV-HCV co-infected patients with HCV genotype 1. Methods: This was a phase III prospective trial. HIV-HCV (genotype 1) co-infected patients from 16 hospitals in Spain were included. These patients received 4 weeks of PEG-IFN/RBV (lead-in),...



Genetic variation associated with cardiovascular risk in autoimmune diseases

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Perrotti, PP, Aterido, A, Fernández-Nebro, A, Cañete, JD, Ferrándiz, C, Tomero, J, Gisbert, JP, Domènech, E, Fernández-Gutiérrez, B, Gomollón, F, García-Planella, E, Fernández, E, Sanmartí, R, Gratacós, J, Martínez-Taboada, VM, Rodríguez-Rodríguez, L, Palau, N, Tortosa, R, Corbeto, ML, Lasanta, ML, Marsal, S, Julià, A

Autoimmune diseases have a higher prevalence of cardiovascular events compared to the general population. The objective of this study was to investigate the genetic basis of cardiovascular disease (CVD) risk in autoimmunity. We analyzed genome-wide genotyping data from 6,485 patients from six autoimmune diseases that are associated with a high socioeconomic impact. First, for each disease, we tested the association of established CVD risk loci. Second, we analyzed the association of autoimmune...



Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study.

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Ceccato A, Dominedò C, Ferrer M, Martin-Loeches I, Barbeta E, Gabarrús A, Cillóniz C, Ranzani OT, De Pascale G, Nogas S, Di Giannatale P, Antonelli M, Torres A

Ventilator-associated pneumonia (VAP) is a leading infectious cause of morbidity in critically ill patients, yet current guidelines offer no indications for follow-up cultures. We aimed to evaluate the role of follow-up cultures and microbiological response 3 days after diagnosing VAP as predictors of short- and long-term outcomes.



Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Cuervo, G, Gasch, O, Shaw, E, Camoez, M, Domínguez, MA, Padilla, B, Pintado, V, Almirante, B, Lepe, JA, López-Medrano, F, de Gopegui, ER, Martínez, JA, Montejo, JM, Perez-Nadales, E, Arnáiz, A, Goenaga, MA, Benito, N, Horcajada, JP, Rodríguez-Baño, J, Pujol, M

Objectives: To compare clinical and microbiological characteristics, treatment and outcomes of MRSA bacteraemia among elderly and younger patients. Material and methods: Prospective study conducted at 21 Spanish hospitals including patients with MRSA bacteraemia diagnosed between June/2008 and December/2009. Episodes diagnosed in patients aged 75 or more years old (>= 75) were compared with the rest of them (<75). Results: Out of 579 episodes of MRSA bacteraemia, 231 (39.9%) occurred in...



Triage decisions for ICU admission: Report from the Task Force of the World Federation of Societies of Intensive and Critical Care Medicine

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Blanch, L, Abillama, FF, Amin, P, Christian, M, Joynt, GM, Myburgh, J, Nates, JL, Pelosi, P, Sprung, C, Topeli, A, Vincent, JL, Yeager, S, Zimmerman, J

Demand for intensive care unit (ICU) resources often exceeds supply, and shortages of ICU beds and staff are likely to persist. Triage requires careful weighing of the benefits and risks involved in ICU admission while striving to guarantee fair distribution of available resources. We must ensure that the patients who occupy ICU beds are those most likely to benefit from the ICU's specialized technology and professionals. Although prognosticating is not an exact science, preference should...



Combination of Thrombolysis and Statins in Acute Stroke Is Safe Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Montaner, J, Bustamante, A, García-Matas, S, Martínez-Zabaleta, M, Jiménez, C, de la Torre, J, Rubio, FR, Segura, T, Masjuán, J, Cánovas, D, Freijo, M, Delgado-Mederos, R, Tejada, J, Lago, A, Bravo, Y, Corbeto, N, Giralt, D, Vives-Pastor, B, de Arce, A, Moniche, F, Delgado, P, Ribó, M

Background and Purpose-The STARS trial (Stroke Treatment With Acute Reperfusion and Simvastatin) was conducted to demonstrate the efficacy and safety of simvastatin treatment in acute stroke. Methods-STARS07 was a multicentre, phase IV, prospective, randomized, double-blind, placebo-controlled trial. Patients with Acute ischemic stroke recruited within 12 hours from symptom onset were randomized to oral simvastatin 40 mg or placebo, once daily for 90 days. Primary outcome was proportion of...



First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Carrato, A, Abad, A, Massuti, B, Grávalos, C, Escudero, P, Longo-Muñoz, F, Manzano, JL, Gómez, A, Safont, MJ, Gallego, J, García-Paredes, B, Pericay, C, Duenas, R, Rivera, F, Losa, F, Valladares-Ayerbes, M, Gonález, E, Aranda, E

Background: In first-line wild-type (WT)-Kirsten rat sarcoma viral oncogene homologue (KRAS) metastatic colorectal cancer (mCRC), panitumumab (Pmab) improves outcomes when added to FOLFOX [folinic acid, 5-fluorouracil, and oxaliplatin] or FOLFIRI [folinic acid, 5-fluorouracil, and irinotecan]. However no trial has directly compared these combinations. Methods: Multicentre, open-label study in untreated patients >= 18 years with (WT)-KRAS mCRC and multiple or unresectable liver-limited...



Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Cserni, G, Zombori, T, Andreu, X, Bianchi, S, Regitnig, P, Amendoeira, I, Balmativola, D, Kovács, A, Cordoba, A, Reiner, A, Kulka, J, Kaya, H, Liepniece-Karele, I, Quinn, C, Kovári, B

Tumor draining sentinel lymph nodes (SLNs) are the sites of selective changes as compared to non-SLNs. They show features of tumor-reactive lymphadenopathy, including increased total number of functional blood vessels, but a relative immunosuppressed status has also been described in them. We explored the hypothesis of a selective regression or non-regression in SLNs versus non-SLNs in 142 patients with 110 estrogen receptor-positive and 32 estrogen receptor-negative tumors undergoing both SLN...



Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Carmona-Bayonas, A, Jimenez-Fonseca, P, Custodio, A, Cánovas, MS, Hernández, R, Pericay, C, Echavarria, I, Lacalle, A, Visa, L, Palomo, AR, Mangas, M, Cano, JM, Buxo, E, Alvarez-Manceñido, F, García, T, Lorenzo, JE, Ferrer-Cardona, M, Viudez, A, Azkarate, A, Ramchandani, A, Arias, D, Longo, F, López, C, Bayona, RS, Limón, ML, Díaz-Serrano, A, Montes, AF, Sala, P, Cerdá, P, Rivera, F, Gallego, J

Background Although anthracycline-based triplets are one of the most widely used schedules to treat advanced gastric cancer (AGC), the benefit of including epirubicin in these therapeutic combinations remains unknown. This study aims to evaluate both the efficacy and tolerance of triplets with epirubicin vs. doublets with platinum-fluoropyrimidine in a national AGC registry. Methods Patients with AGC treated with polychemotherapy without trastuzumab at 28 hospitals in Spain between 2008 and...



Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Shaw, E, Miró, JM, Puig-Asensio, M, Pigrau, C, Barcenilla, F, Murillas, J, Garcia-Pardo, G, Espejo, E, Padilla, B, Garcia-Reyne, A, Pasquau, J, Rodriguez-Baño, J, López-Contreras, J, Montero, M, de la Calle, C, Pintado, V, Calbo, E, Gasch, O, Montejo, M, Salavert, M, Garcia-Pais, MJ, Carratalà, J, Pujol, M

Introduction: Despite the availability of new antibiotics such as daptomycin, methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia continues to be associated with high clinical failure rates. Combination therapy has been proposed as an alternative to improve outcomes but there is a lack of clinical studies. The study aims to demonstrate that combination of daptomycin plus fosfomycin achieves higher clinical success rates in the treatment of MRSA bacteraemia than daptomycin alone....



Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
De Ferrari, GM, Maier, LS, Mont, L, Schwartz, PJ, Simonis, G, Leschke, M, Gronda, E, Boriani, G, Darius, H, Torán, LG, Savelieva, I, Dusi, V, Marchionni, N, Rendón, MQ, Schumacher, K, Tonini, G, Melani, L, Giannelli, S, Maggi, CA, Camm, AJ

BACKGROUND Currently available antiarrhythmic agents for the treatment of atrial fibrillation (AF) have important limitations, leaving an unmet need for safe and effective therapy. Ranolazine is an approved antianginal agent with a favorable safety profile and electrophysiologic properties suggesting a potential role in the treatment of AF. OBJECTIVE The purpose of this study was to assess the safety and efficacy of ranolazine in the prevention of AF recurrence after successful electrical...



Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Lora-Tamayo, J, Euba, G, Cobo, J, Horcajada, JP, Soriano, A, Sandoval, E, Pigrau, C, Benito, N, Falgueras, L, Palomino, J, del Toro, MD, Jover-Sáenz, A, Iribarren, JA, Sánchez-Somolinos, M, Ramos, A, Fernández-Sampedro, M, Riera, M, Baraia-Etxaburu, JM, Ariza, J

Levofloxacin plus rifampicin (L+R) is the treatment of choice for acute staphylococcal prosthetic joint infection (PJI) managed with debridement and implant retention (DAIR). Long courses have been empirically recommended, but some studies have suggested that shorter treatments could be as effective. Our aim was to prove that a short treatment schedule was non-inferior to the standard long schedule. An open-label, multicentre, randomised clinical trial (RCT) was performed. Patients with an...



SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Duran, I, Hagen, C, Arranz, JA, Apellaniz-Ruiz, M, Pérez-Valderrama, B, Sala, N, Lainez, N, García-Del Muro, X, Noguerón, E, Climent, MA, Maroto, P, Font, A, García-Donas, J, Gallardo, E, López-Criado, P, Del Alba, AG, Sáez, MI, Vázquez, S, Luque, R, Rodríguez-Antona, C

We aimed to identify SNPs associated with cabazitaxel toxicity and response within a Phase II clinical trial using this compound in advanced transitional cell carcinoma after progression to a platinum-based regimen. Patients & methods: Eleven SNPs in CYP3A4, CYP3A5, CYP2C8, ABCB1 and TUBB1 were genotyped in 45 patients. Results: CYP3A5 rs776746 A allele was associated with protection against gastrointestinal toxicity (odds ratio: 0.06, 95% CI: 0.007-0.63, p = 0.018) and with reduced...



Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Solans-Laqué, R, Fraile, G, Rodriguez-Carballeira, M, Caminal, L, Castillo, MJ, Martínez-Valle, F, Sáez, L, Rios, JJ, Solanich, X, Oristrell, J, Pasquau, F, Fonseca, E, Zamora, M, Callejas, JL, Frutos, B, Abdilla, M, Fanlo, P, García-Sánchez, I, López-Dupla, M, Sopeña, B, Pérez-Iglesias, A, Bosch, JA

The aim of this study was to describe the clinical characteristics of ANCA-associated vasculitides (AAV) at presentation, in a wide cohort of Spanish patients, and to analyze the impact of the vasculitis type, ANCA specificity, prognostic factors, and treatments administered at diagnosis, in the outcome. A total of 450 patients diagnosed between January 1990 and January 2014 in 20 Hospitals from Spain were included. Altogether, 40.9% had granulomatosis with polyangiitis (GPA), 37.1%...



Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Fonseca, PJ, Carmona-Bayonas, A, Hernández, R, Custodio, A, Cano, JM, Lacalle, A, Echavarria, I, Macias, I, Mangas, M, Visa, L, Buxo, E, Manceñido, FA, Viudez, A, Pericay, C, Azkarate, A, Ramchandani, A, López, C, de Castro, EM, Montes, AF, Longo, F, Bayona, RS, Limón, ML, Diaz-Serrano, A, Carnicero, AM, Arias, D, Cerdà, P, Rivera, F, Vieitez, JM, Cánovas, MS, Garrido, M, Gallego, J

BACKGROUND: The choice of chemotherapy in HER2-negative gastric cancer is based on centre's preferences and adverse effects profile. No schedule is currently accepted as standard, nor are there any factors to predict response, other than HER2 status. We seek to evaluate whether Lauren type influences the efficacy of various chemotherapies and on patient overall survival (OS). METHODS: We have conducted a multicenter study in 31 hospitals. The eligibility criteria include diagnosis of...



Improved prediction of knee osteoarthritis progression by genetic polymorphisms: the Arthrotest Study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Blanco, FJ, Möller, I, Romera, M, Rozadilla, A, Sánchez-Lázaro, JA, Rodríguez, A, Gálvez, J, Forés, J, Monfort, J, Ojeda, S, Moragues, C, Caracuel, MA, Clavaguera, T, Valdés, C, Soler, JM, Orellana, C, Belmonte, MA, Martín, F, Giménez, S, Ucar, E, Pous, J, Bartolomé, N, Artieda, M, Szczypiorska, M, Tejedor, D, Martínez, A, Montell, E, Martínez, H, Herrero, M, Vergés, J

Objective. The aim of this study was to develop a genetic prognostic tool to predict radiographic progression towards severe disease in primary knee OA (KOA) patients. Methods. This investigation was a cross-sectional, retrospective, multicentric association study in 595 Spanish KOA patients. Caucasian patients aged >= 40 years at the time of diagnosis of primary KOA of Kellgren-Lawrence grade 2 or 3 were included. Patients who progressed to Kellgren-Lawrence score 4 or who were referred...



Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Marí-Alfonso, B, Simeón-Aznar, CP, Guillén-Del Castillo, A, Rubio-Rivas, M, Trapiella-Martínez, L, Todolí-Parra, JA, Carballeira, MR, Marín-Ballvé, A, Iniesta-Arandia, N, Colunga-Argüelles, D, Castillo-Palma, MJ, Sáez-Comet, L, Egurbide-Arberas, MV, Ortego-Centeno, N, Freire, M, Hitos, JAV, Chamorro, AJ, Madroñero-Vuelta, AB, Perales-Fraile, I, Pla-Salas, X, Fernández-De-La-Puebla, RA, Fonollosa-Pla, V, Tolosa-Vilella, C

Objective: To assess the prevalence and causes of hepatobiliary involvement (HBI) in systemic sclerosis (SSc), to investigate the clinical characteristics and prognosis of SSc patients with HBI (SSc-HBI) and without HBI (SSc-non-HBI), and to compare both groups according to the cutaneous SSc subsets. Methods: In all, 1572 SSc patients were collected in the RESCLE registry up to January 2015, and all hepatobiliary disturbances were recorded. We investigated the HBI-related characteristics and...



Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
González-López, TJ, Alvarez-Román, MT, Pascual, C, Sánchez-González, B, Fernández-Fuentes, F, Jarque, I, Pérez-Rus, G, Pérez-Crespo, S, Bernat, S, Hernández-Rivas, JA, Andrade, MM, Cortés, M, Gómez-Nuñez, M, Olivera, P, Martínez-Robles, V, Fernández-Rodríguez, A, Fuertes-Palacio, MA, Fernández-Miñano, C, de Cabo, E, Fisac, R, Aguilar, C, Bárez, A, Peñarrubia, MJ, García-Frade, LJ, González-Porras, JR

BackgroundEltrombopag is effective and safe in chronic immune thrombocytopenia (ITP). However, clinical trials may not accurately reflect what happens in clinical practice. We evaluated the efficacy and safety of eltrombopag in primary chronic ITP in a real-world setting. MethodsA total of 164 primary patients with chronic ITP from 40 Spanish centers, who had been treated with eltrombopag, were retrospectively evaluated. ResultsThe median age of our cohort (72% women) was 63 yr (interquartile...



Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Irigoyen, A, Gallego, J, Ponce, CG, Vera, R, Iranzo, V, Ales, I, Aréevalo, S, Pisa, A, Martín, M, Salud, A, Falcó, E, Sáenz, A, Mozo, JLM, Pulido, G, Galáan, JM, Pazo-Cid, R, Rivera, F, García, TG, Serra, O, Parra, EMF, Hurtado, A, Reina, MJG, Gomez, LJL, Esther, MOW, Benavides, M, Aranda, E

Background: Gemcitabine and erlotinib have shown a survival benefit in the first line setting in metastatic pancreatic cancer (mPC). The aim of this study was to assess whether combining capecitabine (C) with gemcitabine + erlotinib (GE) was safe and effective versus GE in patients with mPC. Patients and methods: Previously untreated mPC patients were randomised to receive G (1000 mg/m(2), days 1, 8, 15) + E (100 mg/day, days 1-28) + C (1660 mg/m2, days 1-21) or GE, q4 weeks, until progression...



Dynamic Functional Connectivity Reveals Altered Variability in Functional Connectivity Among Patients With Major Depressive Disorder

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Demirtas, M, Tornador, C, Falcón, C, López-Solà, M, Hernández-Ribas, R, Pujol, J, Menchón, JM, Ritter, P, Cardoner, N, Soriano-Mas, C, Deco, G

Resting-state fMRI (RS-fMRI) has become a useful tool to investigate the connectivity structure of mental health disorders. In the case of major depressive disorder (MDD), recent studies regarding the RS-fMRI have found abnormal connectivity in several regions of the brain, particularly in the default mode network (DMN). Thus, the relevance of the DMN to self-referential thoughts and ruminations has made the use of the resting-state approach particularly important for MDD. The majority of such...



INFLAMMATORY BOWEL DISEASE Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Marín-Jiménez, I, Nos, P, Domènech, E, Riestra, S, Gisbert, JP, Calvet, X, Cortés, X, Iglesias, E, Huguet, JM, Taxonera, C, Fernández, R, Carpio, D, Gutiérrez, A, Guardiola, J, Laria, LC, Sicilia, B, Bujanda, L, Cea-Calvo, L, Romero, C, Rincón, O, Juliá, B, Panés, J

OBJECTIVES: New e-health technologies can improve patient-physician communication and contribute to optimal patient care. We compared the diagnostic performance of the Simple Clinical Colitis Activity Index (SCCAI) self-administered by patients with ulcerative colitis (UC) at home (through a website) with the in-clinic gastroenterologist-assessed SCCAI. METHODS: Patients were followed-up over 6 months. At months 3 and 6, patients completed the SCCAI online at home; within 48 h,...



Therapeutic management of peritonitis: a comprehensive guide for intensivists

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Montravers, P, Blot, S, Dimopoulos, G, Eckmann, C, Eggimann, P, Guirao, X, Paiva, JA, Sganga, G, De Waele, J

The management of peritonitis in critically ill patients is becoming increasingly complex due to their changing characteristics and the growing prevalence of multidrug-resistant (MDR) bacteria. A multidisciplinary panel summarizes the latest advances in the therapeutic management of these critically ill patients. Appendicitis, cholecystitis and bowel perforation represent the majority of all community-acquired infections, while most cases of healthcare-associated infections occur following...



Efficacy of Anakinra in Refractory Adult-Onset Still's Disease <i>Multicenter Study of 41 Patients and Literature Review</i>

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Ortiz-Sanjuán, F, Blanco, R, Riancho-Zarrabeitia, L, Castaneda, S, Olivé, A, Riveros, A, Velloso-Feijoo, ML, Narváez, J, Jiménez-Moleón, I, Maiz-Alonso, O, Ordóñez, C, Bernal, JA, Hernández, MV, Sifuentes-Giraldo, WA, Gómez-Arango, C, Galíndez-Agirregoikoa, E, Blanco-Madrigal, J, Ortiz-Santamaria, V, del Blanco-Barnusell, J, De Dios, JR, Moreno, M, Fiter, J, de los Riscos, M, Carreira, P, Rodriguez-Valls, MJ, González-Vela, MC, Calvo-Río, V, Loricera, J, Palmou-Fontana, N, Pina, T, Llorca, J, González-Gay, MA

Adult-onset Still's disease (AOSD) is often refractory to standard therapy. Anakinra (ANK), an interleukin-1 receptor antagonist, has demonstrated efficacy in single cases and small series of AOSD. We assessed the efficacy of ANK in a series of AOSD patients.Multicenter retrospective open-label study. ANK was used due to lack of efficacy to standard synthetic immunosuppressive drugs and in some cases also to at least 1 biologic agent.Forty-one patients (26women/15 men) were recruited. They...



Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Trapiella-Martínez, L, Díaz-López, JB, Caminal-Montero, L, Tolosa-Vilella, C, Castillo, AGD, Colunga-Argüelles, D, Rubio-Rivas, M, Iniesta-Arandia, N, Castillo-Palma, MJ, Sáez-Comet, L, Egurbide-Arberas, MV, Ortego-Centeno, N, Freire, M, Vargas-Hitos, JA, Ríos-Blanco, JJ, Todolí-Parra, JA, Rodríguez-Carballeira, M, Marín-Ballvé, A, Chamorro-Fernández, AJ, Pla-Salas, X, Madroñero-Vuelta, AB, Ruiz-Muñóz, M, Fonollosa-Pla, V, Simeón-Aznar, CP

Objectives: According to the existence of subclinical organ involvement pre-scleroderma should be divided into two subsets: very early and early disease. Pre-scleroderma patients included in the Spanish Scleroderma Registry (RESCLE) Cohort were reclassified into subsets. Differences were evaluated and the risk of progression to definite systemic sclerosis was estimated. Methods: The characteristics of very early and early SSc patients were compared. A logistic regression model was used to...



Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Bonanad, S, De la Rubia, J, Gironella, M, Persona, EP, González, B, Digo, CF, Arnan, M, Zudaire, M, Rivas, JAH, Soler, A, Marrero, C, Olivier, C, Altés, A, Valcárcel, D, Hernández, MT, Oiartzabal, I, Ordoño, RF, Arnao, M, Esquerra, A, Sarrá, J, González-Barca, E, González, J, Calvo, X, Nomdedeu, M, Guiñón, AG, Payer, AR, Casado, A, López, S, Durán, M, Marcos, M, Cruz-Jentoft, AJ

Materials and Methods: The 30-item GAR scale was designed through a multi-step process to cover 8 relevant dimensions. This is an observational study conducted in 363 patients aged >= 65 years, newly diagnosed with different hematological malignancies (myelodysplasic syndrome/acute myeloblastic leukemia, multiple myeloma, or chronic lymphocytic leukemia), and treatment-naive. The scale psychometric validation process included the analyses of feasibility, floor and ceiling effect, validity...



Mammographic density and breast cancer in women from high risk families

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Cajal, TRY, Chirivella, I, Miranda, J, Teule, A, Izquierdo, A, Balmaña, J, Sánchez-Heras, AB, Llort, G, Fisas, D, Lope, V, Hernández-Agudo, E, Juan-Fita, MJ, Tena, I, Robles, L, Guillén-Ponce, C, Pérez-Segura, P, Luque-Molina, MS, Hernando-Polo, S, Salinas, M, Brunet, J, Salas-Trejo, MD, Barnadas, A, Pollán, M

Introduction: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype. Methods: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling...



Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Lens, S, Fernández, I, Rodríguez-Tajes, S, Hontangas, V, Vergara, M, Forné, M, Calleja, JL, Diago, M, Llaneras, J, Llerena, S, Torras, X, Sacristán, B, Roget, M, Fernández-Rodríguez, CM, Navascués, MC, Fuentes, J, Sánchez-Ruano, JJ, Simón, MA, Sáez-Royuela, F, Baliellas, C, Morillas, R, Forns, X

OBJECTIVES: Interferon-free therapies have an improved safety and efficacy profile. However, data in elderly patients, who have frequently advanced liver disease, associated comorbidities, and use concomitant medications are scarce. The im of this study was to assess the effectiveness and tolerability of all-oral regimens in elderly patients in real-life clinical practice. METHODS: Retrospective analysis of hepatitis C virus (HCV) patients aged >= 65 years receiving interferon-free regimens...



Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Freire, M, Rivera, A, Sopeña, B, Vilella, CT, Guillén-Del Castillo, A, Argüelles, DC, Rubio, JLC, Rivas, MR, Martínez, LT, Parra, JAT, Carballeira, MR, Arandia, NI, Hernández, FJG, Arberas, MVE, Comet, LS, Hitos, JAV, Blanco, JJR, Ballvé, AM, Salas, XP, Vuelta, ABM, Muñoz, MR, Pla, VF, Aznar, CPS

Objective. The low overall prevalence of systemic sclerosis (SSc) and the low proportion of male patients have resulted in a scarcity of studies assessing sex differences in Ssc patients, and contradictory results have often been show among those studies that have been performed. Methods. A prospective study was conducted with the Spanish RESCLE register to analyse the influence of gender on survival of SSc patients. Results. In total, 1506 SSc patients (1341 women, 165 men) were recruited...



A Quantile Analysis of Plateau and Driving Pressures: Effects on Mortality in Patients With Acute Respiratory Distress Syndrome Receiving Lung-Protective Ventilation

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Villar, J, Martín-Rodríguez, C, Domínguez-Berrot, AM, Fernández, L, Ferrando, C, Soler, JA, Díaz-Lamas, AM, González-Higueras, E, Nogales, L, Ambrós, A, Carriedo, D, Hernández, M, Martínez, D, Blanco, J, Belda, J, Parrilla, D, Suárez-Sipmann, F, Tarancón, C, Mora-Ordoñez, JM, Blanch, L, Pérez-Méndez, L, Fernández, RL, Kacmarek, RM

Objectives: The driving pressure (plateau pressure minus positive end-expiratory pressure) has been suggested as the major determinant for the beneficial effects of lung-protective ventilation. We tested whether driving pressure was superior to the variables that define it in predicting outcome in patients with acute respiratory distress syndrome. Design: A secondary analysis of existing data from previously reported observational studies. Setting: A network of ICUs. Patients: We studied 778...



Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Arandia, NI, Simeón-Aznar, CP, del Castillo, AG, Argüelles, DC, Rubio-Rivas, M, Martínez, LT, Hernández, FJG, Comet, LS, Arberas, MVE, Ortego-Centeno, N, Freire, M, Alfonso, BM, Hitos, JAV, Blanco, JJR, Parra, JAT, Rodríguez-Carballeira, M, Ballvé, AM, Fernández, AJC, Salas, XP, Vuelta, ABM, Muñoz, MR, Pla, VF, Espinosa, G

Objective. To assess the clinical manifestations and prognosis of Spanish patients with systemic sclerosis (SSc) according to their immunological profile. Methods. From the Spanish Scleroderma Study Group or RESCLE (Registro de ESCLErodermia as Spanish nomenclature) Registry we selected those patients in which anti-centromere (ACA), anti-topoisomerase I (ATA), and anti-RNA polymerase III (ARA) antibodies had been determined, and a single positivity for each SSc specific antibody was detected....



Obstructive sleep disordered breathing in 2-to 18-year-old children: diagnosis and management

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Kaditis, AG, Alvarez, MLA, Boudewyns, A, Alexopoulos, EI, Ersu, R, Joosten, K, Larramona, H, Miano, S, Narang, I, Trang, H, Tsaoussoglou, M, Vandenbussche, N, Villa, MP, Van Waardenburg, D, Weber, S, Verhulst, S

This document summarises the conclusions of a European Respiratory Society Task Force on the diagnosis and management of obstructive sleep disordered breathing (SDB) in childhood and refers to children aged 2-18 years. Prospective cohort studies describing the natural history of SDB or randomised, double-blind, placebo-controlled trials regarding its management are scarce. Selected evidence (362 articles) can be consolidated into seven management steps. SDB is suspected when symptoms or...



Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Custodio, A, Carmona-Bayonas, A, Jiménez-Fonseca, P, Sánchez, ML, Viudez, A, Hernández, R, Cano, JM, Echavarria, I, Pericay, C, Mangas, M, Visa, L, Buxo, E, García, T, Palomo, AR, Manceñido, FA, Lacalle, A, Macias, I, Azkarate, A, Ramchandani, A, Montes, AF, López, C, Longo, F, Bayona, RS, Limón, ML, Díaz-Serrano, A, Hurtado, A, Madero, R, Gómez, C, Gallego, J

Background: To develop and validate a nomogram and web-based calculator to predict overall survival (OS) in Caucasian-advanced oesophagogastric adenocarcinoma (AOA) patients undergoing first-line combination chemotherapy. Methods: Nine hundred twenty-four AOA patients treated at 28 Spanish teaching hospitals from January 2008 to September 2014 were used as derivation cohort. The result of an adjusted-Cox proportional hazards regression was represented as a nomogram and web-based calculator....



Characterization and risk estimate of cancer in patients with primary Sjogren syndrome

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Brito-Zerón, P, Kostov, B, Fraile, G, Caravia-Durán, D, Maure, B, Rascón, FJ, Zamora, M, Casanovas, A, Lopez-Dupla, M, Ripoll, M, Pinilla, B, Fonseca, E, Akasbi, M, de la Red, G, Duarte-Millán, MA, Fanlo, P, Guisado-Vasco, P, Pérez-Alvarez, R, Chamorro, AJ, Morcillo, C, Jiménez-Heredia, I, Sánchez-Berná, I, López-Guillermo, A, Ramos-Casals, M

Background: The purpose of this study is to characterize the risk of cancer in a large cohort of patients with primary Sjogren syndrome (SjS). Methods: We had analyzed the development of cancer in 1300 consecutive patients fulfilling the 2002 SjS classification criteria. The baseline clinical and immunological characteristics and systemic activity (ESSDAI scores) were assessed at diagnosis as predictors of cancer using Cox proportional hazards regression analysis adjusted for age at diagnosis...



Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Carrera-Lasfuentes, P, Lanas, A, Bujanda, L, Strunk, M, Quintero, E, Santolaria, S, Benito, R, Sopena, F, Piazuelo, E, Thomson, C, Perez-Aisa, A, Nicolas-Perez, D, Hijona, E, Espinel, J, Campo, R, Manzano, M, Geijo, F, Pellise, M, Zaballa, M, Gonzalez-Huix, F, Espinos, J, Tito, L, Barranco, L, D'Amato, M, Garcia-Gonzalez, MA

Variations in DNA repair genes have been reported as key factors in gastric cancer (GC) susceptibility but results among studies are inconsistent. We aimed to assess the relevance of DNA repair gene polymorphisms and environmental factors to GC risk and phenotype in a Caucasian population in Spain. Genomic DNA from 603 patients with primary GC and 603 healthy controls was typed for 123 single nucleotide polymorphisms in DNA repair genes using the Illumina platform. Helicobacter pylori infection...



End-of-life care in the intensive care unit: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Myburgh, J, Abillama, F, Chiumello, D, Dobb, G, Jacobe, S, Kleinpell, R, Koh, Y, Martin, C, Michalsen, A, Pelosi, P, Torra, LB, Vincent, JL, Yeager, S, Zimmerman, J

End-of-life care in the intensive care unit (ICU) was identified as an objective in a series of Task Forces developed by the World Federation of Societies of Intensive and Critical Care Medicine Council in 2014. The objective was to develop a generic statement about current knowledge and to identify challenges relevant to the global community that may inform regional and local initiatives. An updated summary of published statements on end-of-life care in the ICU from national Societies is...



Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Sorio, R, Roemer-Becuwe, C, Hilpert, F, Gibbs, E, García, Y, Kaern, J, Huizing, M, Witteveen, P, Zagouri, F, Coeffic, D, Lück, HJ, González-Martín, A, Kristensen, G, Levaché, CB, Lee, CK, Gebski, V, Pujade-Lauraine, E

Background. The AURELIA trial demonstrated significantly improved progression-free survival (PPS) with bevacizumab added to chemotherapy for platinum-resistant ovarian cancer (PROC). Methods. Patients with PROC were randomised to receive investigator-selected single-agent chemotherapy alone or with bevacizumab. Post-hoc exploratory analyses assessed efficacy, safety and patient-reported outcomes according to age <65 versus 265 years. Results. In the 133 patients (37%) aged >= 65 years,...



Severe, life-threatening phenotype of primary Sjogren's syndrome: clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Flores-Chávez, A, Kostov, B, Solans, R, Fraile, G, Maure, B, Feijoo-Massó, C, Rascón, FJ, Pérez-Alvarez, R, Zamora-Pasadas, M, García-Pérez, A, Lopez-Dupla, M, Duarte-Millán, MA, Ripoll, M, Fonseca-Aizpuru, E, Guisado-Vasco, P, Pinilla, B, de-la-Red, G, Chamorro, AJ, Morcillo, C, Fanlo, P, Soto-Cárdenas, MJ, Retamozo, S, Ramos-Casals, M, Brito-Zerón, P

Objective. To analyse the clinical features and outcomes of patients presenting with life-threatening systemic disease in a large cohort of Spanish patients with primary Sjogren's syndrome (SS). Methods. The GEAS-SS multicentre registry was formed in 2005 with the aim of collecting a large series of Spanish patients with primary SS, and included more than 20 Spanish reference centres with substantial experience in the management of SS patients. By January 2018, the database included 1580...



Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Chaparro, M, Ramas, M, Benítez, JM, López-García, A, Juan, A, Guardiola, J, Mínguez, M, Calvet, X, Márquez, L, Salazar, LIF, Bujanda, L, García, C, Zabana, Y, Lorente, R, Barrio, J, Hinojosa, E, Iborra, M, Cajal, MD, Van Domselaar, M, García-Sepulcre, MF, Gomollón, F, Piqueras, M, Alcaín, G, García-Sánchez, V, Panés, J, Doménech, E, García-Esquinas, E, Rodríguez-Artalejo, F, Gisbert, JP

OBJECTIVES: The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b) To estimate the incidence rate of EC; (c) To evaluate the association between EC and treatment with immunosuppressants and anti-tumor necrosis factor (TNF) agents. METHODS: This was an observational cohort study. Inclusion criteria: IBD and inclusion in the ENEIDA Project (a prospectively maintained registry) from GETECCU....



The microbiome in respiratory medicine: current challenges and future perspectives

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Faner, R, Sibila, O, Agustí, A, Bernasconi, E, Chalmers, JD, Huffnagle, GB, Manichanh, C, Molyneaux, PL, Paredes, R, Brocal, VP, Ponomarenko, J, Sethi, S, Dorca, J, Monsó, E

The healthy lung has previously been considered to be a sterile organ because standard microbiological culture techniques consistently yield negative results. However, culture-independent techniques report that large numbers of microorganisms coexist in the lung. There are many unknown aspects in the field, but available reports show that the lower respiratory tract microbiota: 1) is similar in healthy subjects to the oropharyngeal microbiota and dominated by members of the Firmicutes,...



Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Sepúlveda, M, Aldea, M, Escudero, D, Llufriu, S, Arrambide, G, Otero-Romero, S, Sastre-Garriga, J, Romero-Pinel, L, Martínez-Yélamos, S, Sola-Valls, N, Armangué, T, Sotoca, J, Escartín, A, Robles-Cedeño, R, Ramió-Torrent, L, Presas-Rodríguez, S, Ramo-Tello, C, Munteis, E, Pelayo, R, Gubieras, L, Brieva, L, Ortiz, N, Hervás, M, Mañé-Martínez, MA, Cano, A, Vela, E, Tintoré, M, Blanco, Y, Montalban, X, Graus, F, Saiz, A

Background: Population-based studies on neuromyelitis optica spectrum disorders (NMOSD) are limited, and it is unclear whether the rates have changed with the implementation of the new 2015 criteria. Objectives: To estimate the incidence and prevalence of NMOSD in Catalonia (Spain), using both the 2006 and the 2015 criteria. Methods: In this clinic-based retrospective study, patients diagnosed with NMOSD between 2006 and 2015 were identified using multiple sources, including direct contact to...



Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Barreiro-de Acosta, M, Marín-Jiménez, I, Panadero, A, Guardiola, J, Cañas, M, Montoya, MG, Modino, Y, Alcaín, G, Bosca-Watts, MM, Calvet, X, Casellas, F, Chaparro, M, Salazar, LF, Ferreiro-Iglesias, R, Ginard, D, Iborra, M, Manceñido, N, Mañosa, M, Merino, O, Rivero, M, Roncero, O, Sempere, L, Vega, P, Zabana, Y, Mínguez, M, Nos, P, Gisbert, JP

Aims: To establish recommendations for the management of psychological problems affecting patients with inflammatory bowel disease (IBD). Methods: A meeting of a group of IBD experts made up of doctors, psychologists, nurses and patient representatives was held. The following were presented: 1) Results of a previous focal group, 2) Results of doctor and patient surveys, 3) Results of a systematic review of tools for detecting anxiety and depression. A guided discussion was then held about the...



Intervention to Prevent Major Depression in Primary Care A Cluster Randomized Trial

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Bellón, JA, Conejo-Cerón, S, Moreno-Peral, P, King, M, Nazareth, I, Martín-Pérez, C, Fernández-Alonso, C, Rodríguez-Bayón, A, Fernández, A, Aiarzaguena, JM, Montón-Franco, C, Ibanez-Casas, I, Rodríguez-Sánchez, E, Ballesta-Rodríguez, MI, Serrano-Blanco, A, Gómez, MC, LaFuente, P, Muñoz-García, MD, Mínguez-Gonzalo, P, Araujo, L, Palao, D, Bully, P, Zubiaga, F, Navas-Campaña, D, Mendive, J, Aranda-Regules, JM, Rodriguez-Morejón, A, Salvador-Carulla, L, Luna, JD

Background: Not enough is known about universal prevention of depression in adults. Objective: To evaluate the effectiveness of an intervention to prevent major depression. Design: Multicenter, cluster randomized trial with sites randomly assigned to usual care or an intervention. (ClinicalTrials.gov:NCT01151982) Setting: 10 primary care centers in each of 7 cities in Spain. Participants: Two primary care physicians (PCPs) and 5236 nondepressed adult patients were randomly sampled from each...



Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Sanchez, R, Ayala, R, Alonso, RA, Martínez, MP, Ribera, J, García, O, Sanchez-Pina, J, Mercadal, S, Montesinos, P, Martino, R, Barba, P, González-Campos, J, Barrios, M, Lavilla, E, Gil, C, Bernal, T, Escoda, L, Abella, E, Amigo, ML, Moreno, MJ, Bravo, P, Guàrdia, R, Hernández-Rivas, JM, García-Guiñón, A, Piernas, S, Ribera, JM, Martínez-López, J

We investigated the frequency, predictors, and evolution of acute lymphoblastic leukemia (ALL) in patients with CNS relapse and introduced a novel method for studying BCR-ABL1 protein variants in cDNA from bone marrow (BM) and cerebrospinal fluid (CSF) blast cells. A total of 128 patients were analyzed in two PETHEMA clinical trials. All achieved complete remission after imatinib treatment. Of these, 30 (23%) experienced a relapse after achieving complete remission, and 13 (10%) had an isolated...



Melanoma Incidence Increases in the Elderly of Catalonia But Not in the Younger Population: Effect of Prevention or Consequence of Immigration?

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Puig, S, Marcoval, J, Paradelo, C, Azon, A, Bartralot, R, Bel, S, Bigata, X, Boada, A, Campoy, A, Carrera, C, Curco, N, Dalmau, J, Ferrandiz, C, Ferreres, JR, FormigoN', M, Gallardo, F, Gonzalez, A, Just, M, Llistosella, E, Marti, RM, Nogues, ME, Pedragosa, R, Pujol, JA, Roldán-Marín, R, Sabat, M, Salleras, M, Smandia, JA, Zaballos, P, Plana, E, Malvehy, J

All cases of malignant melanoma diagnosed in 23 hospitals in Catalonia, from 2000 to 2007 were recorded and melanoma incidence calculated and adjusted for the European standard population via the direct method. The age standardised rate/100,000 inhabitants varied from 6.74 in 2000 to 8.64 in 2007 for all melanomas and from 4.79 to 5.80 for invasive melanomas; the Breslow thickness was stable during the period. The increase in invasive melanoma incidence in the elderly was remarkable, the crude...



Personalized Respiratory Medicine: Exploring the Horizon, Addressing the Issues Summary of a BRN-AJRCCM Workshop Held in Barcelona on June 12, 2014

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Agustí, A, Antó, JM, Auffray, C, Barbé, F, Barreiro, E, Dorca, J, Escarrabill, J, Faner, R, Furlong, LI, Garcia-Aymerich, J, Gea, J, Lindmark, B, Monsó, E, Plaza, V, Puhan, MA, Roca, J, Ruiz-Manzano, J, Sampietro-Colom, L, Sanz, F, Serrano, L, Sharpe, J, Sibila, O, Silverman, EK, Sterk, PJ, Sznajder, JI

This Pulmonary Perspective summarizes the content and main conclusions of an international workshop on personalized respiratory medicine coorganized by the Barcelona Respiratory Network (www.brn.cat) and the AJRCCM in June 2014. It discusses (1) its definition and historical, social, legal, and ethical aspects; (2) the view from different disciplines, including basic science, epidemiology, bioinformatics, and network/systems medicine; (3) the bottlenecks and opportunities identified by some...



Analysis of <i>ATP8B4</i> F436L Missense Variant in a Large Systemic Sclerosis Cohort

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
López-Isac, E, Bossini-Castillo, L, Palma, AB, Assassi, S, Mayes, MD, Simeón, CP, Ortego-Centeno, N, Vicente, E, Tolosa, C, Rubio-Rivas, M, Román-Ivorra, JA, Beretta, L, Moroncini, G, Hunzelmann, N, Distler, JHW, Riemekasten, G, de Vries-Bouwstra, J, Voskuyl, AE, Radstake, TRDJ, Herrick, A, Denton, CP, Fonseca, C, Martín, J




Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Martin-Loeches, I, Povoa, P, Rodríguez, A, Curcio, D, Suarez, D, Mira, JP, Cordero, ML, Lepecq, R, Girault, C, Candelas, C, Seguin, P, Paulino, C, Messika, J, Castro, AG, Valles, J, Coelho, L, Rabello, L, Lisboa, T, Collins, D, Torres, A, Salluh, J, Nseir, S

Background Ventilator-associated tracheobronchitis has been suggested as an intermediate process between tracheobronchial colonisation and ventilator-associated pneumonia in patients receiving mechanical ventilation. We aimed to establish the incidence and effect of ventilator-associated tracheobronchitis in a large, international patient cohort. Methods We did a multicentre, prospective, observational study in 114 intensive care units (ICU) in Spain, France, Portugal, Brazil, Argentina,...



Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
del Campo, R, Royuela, A, Quintana-Gallego, E, Cobo, M, de la Pedrosa, EGG, Solé, A, Cortell, I, Asensio, O, García, G, Martínez, MT, Cols, M, Salcedo, A, Vázquez, C, Baranda, F, Girón, R, Quintana, E, Delgado, I, de Miguel, MA, García, M, Oliva, C, Prados, MC, Barrio, MI, Pastor, MD, Olveira, C, de Gracia, J, Alvarez, A, Escribano, A, Castillo, S, Figuerola, J, Togores, B, Oliver, A, López, C, Caballero, JD, Tato, M, Máiz, L, Suárez, L, Cantón, R

Background: Clinical and demographical knowledge on Spanish cystic fibrosis (CF) patients is incomplete as no national registry exists. CF-microbiology has not been studied at national level. The results of the first Spanish multicenter study on CF microbiology are presented. Methods: 24 CF-Units for adult (n = 12) and pediatric (n = 12) patients from 17 hospitals provided sputa and clinical data from 15 consecutive patients. Cultures and susceptibility testing were performed. Colonization...



ERS statement on obstructive sleep disordered breathing in 1-to 23-month-old children

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Kaditis, AG, Alvarez, MLA, Boudewyns, A, Abel, F, Alexopoulos, EI, Ersu, R, Joosten, K, Larramona, H, Miano, S, Narang, I, Tan, HL, Trang, H, Tsaoussoglou, M, Vandenbussche, N, Villa, MP, Van Waardenburg, D, Weber, S, Verhulst, S

The present statement was produced by a European Respiratory Society Task Force to summarise the evidence and current practice on the diagnosis and management of obstructive sleep disordered breathing (SDB) in children aged 1-23 months. A systematic literature search was completed and 159 articles were summarised to answer clinically relevant questions. SDB is suspected when symptoms or abnormalities related to upper airway obstruction are identified. Morbidity (pulmonary hypertension, growth...



Trends in Bariatric Surgery in Spain in the Twenty-First Century: Baseline Results and 1-Month Follow Up of the RICIBA, a National Registry

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Lecube, A, de Hollanda, A, Calañas, A, Vilarrasa, N, Rubio, M, Breton, I, Goday, A, Vidal, J, Iglesias, P, Fernández-Soto, ML, Pellitero, S, de Cos, A, Morales, M, Campos, C, Masmiquel, L, Tinahones, F, Pujante, P, García-Luna, P, Bueno, M, Cámara, R, Bandrés, O, Caixàs, A

Specific data is needed to safely expand bariatric surgery and to preserve good surgical outcomes in response to the non-stop increase in obesity prevalence worldwide. The aims of this study are to provide an overview of the baseline characteristics, type of surgery, and 30-day postoperative morbidity and mortality in patients undergoing bariatric surgery in Spanish public hospitals, and evaluate changes throughout the 2000-2014 period. This is a descriptive study using data from the RICIBA,...



Care pathways for the selection of a biologic in severe asthma

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Bousquet, J, Brusselle, G, Buhl, R, Busse, WW, Cruz, AA, Djukanovic, R, Domingo, C, Hanania, NA, Humbert, M, Gow, AM, Phipatanakul, W, Wahn, U, Wechsler, ME




Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Ordás, I, Domènech, E, Mañosa, M, García-Sánchez, V, Iglesias-Flores, E, Peñalva, M, Cañas-Ventura, A, Merino, O, Fernández-Bañares, F, Gomollón, F, Vera, M, Gutiérrez, A, Garcia-Planella, E, Chaparro, M, Aguas, M, Gento, E, Muñoz, F, Aguirresarobe, M, Muñoz, C, Fernández, L, Calvet, X, Jiménez, CE, Montoro, MA, Mir, A, De Castro, ML, García-Sepulcre, MF, Bermejo, F, Panés, J, Esteve, M

OBJECTIVES: To determine the efficacy and safety of cyclosporine (CyA) in a large national registry-based population of patients with steroid-refractory (SR) acute severe ulcerative colitis (ASUC) and to establish predictors of efficacy and adverse events. METHODS: Multicenter study of SR-ASUC treated with CyA, based on data from the ENEIDA registry. SR-ASUC patients treated with infliximab (IFX) or sequential rescue therapy (CyA-IFX or IFX-CyA) were used as comparators. RESULTS: Of 740 SR...



Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Algarra, SM, Soriano, V, Fernández-Morales, L, Berciano-Guerrero, MA, Mujika, K, Manzano, JL, Hernández, TP, Soria, A, Rodríguez-Abreu, D, Arranz, EE, Martínez, JM, Márquez-Rodas, I, Rubió-Casadevall, J, Ortega, ME, García, JMJ, Biurrun, MJL, Palacio, I, Artacho, MRD, Altozano, JP, Rubio, VEC, García, A, Luna, P, Ballesteros, A, Fernández, O, Martín, JAL, Berrocal, A, Arance, A

The main objective of the study was to evaluate the efficacy and safety of dabrafenib alone or combined with trametinib for compassionate use in patients with metastatic melanoma.This retrospective, observational study involved 135 patients with unresectable stage IIIC or stage IV melanoma from an expanded-access program at 30 Spanish centers.Forty-eight patients received dabrafenib monotherapy and 87 received combination dabrafenib and trametinib; 4.4% and 95.6% of the patients had stage IIIC...



Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
López-Sanromán, A, Vera-Mendoza, I, Domènech, E, Taxonera, C, Ruiz, VV, Marín-Jiménez, I, Guardiola, J, Castro, L, Esteve, M, Iglesias, E, Ceballos, D, Martínez-Montiel, P, Gisbert, JP, Mínguez, M, Echarri, A, Calvet, X, Barrio, J, Hinojosa, J, Martín-Arranz, MD, Márquez-Mosquera, L, Bermejo, F, Rimola, J, Pons, V, Nos, P

Background and Aims: Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis is administered. Evidence for optimal treatment is lacking. Our aim was to compare the efficacy of adalimumab [ADA] and azathioprine [AZA] in this setting. Methods: We performed a phase 3, 52-week, multicentre, randomised, superiority study [APPRECIA], in which patients with ileocolonic resection were randomised either to ADA 160-80-40 mg subcutaneously [SC] or AZA 2.5 mg/kg/day,...



Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Guerra, I, Pérez-Jeldres, T, Iborra, M, Algaba, A, Monfort, D, Calvet, X, Chaparro, M, Mañosa, M, Hinojosa, E, Minguez, M, de Zarate, JO, Márquez, L, Prieto, V, García-Sánchez, V, Guardiola, J, Rodriguez, GE, Martín-Arranz, MD, García-Tercero, I, Sicilia, B, Masedo, A, Lorente, R, Rivero, M, Fernández-Salazar, L, Gutiérrez, A, Van Domselaar, M, López-SanRomán, A, Ber, Y, García-Sepulcre, M, Ramos, L, Bermejo, F, Gisbert, JP

Background: Psoriasis induced by anti-tumor necrosis factor-alpha (TNF) therapy has been described as a paradoxical side effect. Aim: To determine the incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in a large nationwide cohort of inflammatory bowel disease patients. Methods: Patients with inflammatory bowel disease were identified from the Spanish prospectively maintained Estudio Nacional en Enfermedad Inflamatoria Intestinal sobre Determinantes...



Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Casanova, MJ, Chaparro, M, Molina, B, Merino, O, Batanero, R, Dueñas-Sadornil, C, Robledo, P, Garcia-Albert, AM, Gómez-Sánchez, MB, Calvet, X, Trallero, MD, Montoro, M, Vázquez, I, Charro, M, Barragán, A, Martínez-Cerezo, F, Megias-Rangil, I, Huguet, JM, Marti-Bonmati, E, Calvo, M, Campderá, M, Muñoz-Vicente, M, Merchante, A, Avila, AD, Serrano-Aguayo, P, De Francisco, R, Hervías, D, Bujanda, L, Rodriguez, GE, Castro-Laria, L, Barreiro-de Acosta, M, Van Domselaar, M, de la Piscina, PR, Santos-Fernández, J, Algaba, A, Torra, S, Pozzati, L, López-Serrano, P, Arribas, MD, Rincón, ML, Peláez, AC, Castro, E, García-Herola, A, Santander, C, Hernández-Alonso, M, Martín-Noguerol, E, Gómez-Lozano, M, Monedero, T, Villoria, A, Figuerola, A, Castaño-García, A, Banales, JM, Díaz-Hernández, L, Argüelles-Arias, F, López-Díaz, J, Pérez-Martínez, I, García-Talavera, N, Nuevo-Siguairo, OK, Riestra, S, Gisbert, JP

Background and Aims: This study sought to determine the prevalence of malnutrition in patients with inflammatory bowel disease, to analyse the dietary beliefs and behaviours of these patients, to study their body composition, to evaluate their muscular strength and to identify the factors associated with malnutrition in these patients. Methods: This was a prospective, multicentre study. Crohn's disease and ulcerative colitis patients from 30 Spanish centres, from the outpatient clinics,...



Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Iborra, M, Pérez-Gisbert, J, Bosca-Watts, MM, López-García, A, García-Sánchez, V, López-Sanromán, A, Hinojosa, E, Márquez, L, García-López, S, Chaparro, M, Aceituno, M, Calafat, M, Guardiola, J, Belloc, B, Ber, Y, Bujanda, L, Beltrán, B, Rodríguez-Gutiérrez, C, Barrio, J, Cabriada, JL, Rivero, M, Camargo, R, van Domselaar, M, Villoria, A, Schuterman, HS, Hervás, D, Nos, P

Background Ulcerative colitis (UC) treatment is focused to achieve mucosal healing, avoiding disease progression. The study aimed to evaluate the real-world effectiveness of adalimumab (ADA) in UC and to identify predictors of remission to ADA. Methods This cohort study used data from the ENEIDA registry. Clinical response, clinical remission, endoscopic remission, adverse events (AE), colectomy, and hospitalisations were evaluated; baseline characteristics and biological parameters were...



Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Sternberg, C, Armstrong, A, Pili, R, Ng, S, Huddart, R, Agarwal, N, Khvorostenko, D, Lyulko, O, Brize, A, Vogelzang, N, Delva, R, Harza, M, Thanos, A, James, N, Werbrouck, P, Bögemann, M, Hutson, T, Milecki, P, Chowdhury, S, Gallardo, E, Schwartsmann, G, Pouget, JC, Baton, F, Nederman, T, Tuvesson, H, Carducci, M

Purpose Tasquinimod, a novel oral therapy targeting the tumor microenvironment, significantly improved progression-free survival (PFS) in a randomized, placebo-controlled phase II trial in men with metastatic castration-resistant prostate cancer (mCRPC). This phase III study was conducted to confirm the phase II results and to detect an overall survival (OS) benefit. Patients and Methods Men with chemotherapy-naive mCRPC and evidence of bone metastases were assigned (2: 1) to receive...



Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Folprecht, G, Pericay, C, Saunders, MP, Thomas, A, Lopez, RL, Roh, JK, Chistyakov, V, Höhler, T, Kim, JS, Hofheinz, RD, Ackland, SP, Swinson, D, Kopp, M, Udovitsa, D, Hall, M, Iveson, T, Vogel, A, Zalcberg, JR

Background: The combination of aflibercept with FOLFIRI has been shown to significantly prolong overall survival in patients with metastatic colorectal cancer (mCRC) after progression on oxaliplatin-based therapy. This trial evaluated the addition of aflibercept to oxaliplatin-based first-line treatment of patients with mCRC. Patients with mCRC were randomized to receive first-line therapy with mFOLFOX6 plus aflibercept (4 mg/kg) or mFOLFOX6 alone. The primary end point of this phase II study...



A multifaceted educational intervention shortened time to antibiotic administration in children with severe sepsis and septic shock: ABISS Edusepsis pediatric study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Esteban, E, Belda, S, García-Soler, P, Rodríguez-Núñez, A, Calvo, C, Gil-Anton, J, Bustinza, A, Iglesias-Bouzas, MI, Pujol-Jove, M, Decarlos, JC, García-Iñiguez, JP, Pérez-Iranzo, A, Téllez, C, Ortiz, I, Pérez, R, Bonil, V, Brio, S, Concha, A, López, JD, Murga, V, Flores, JC, Trujillo, A, Felipe, A, Abadesso, C, Pino, M, León, J, Martínez, MC, Gómez, F, Pérez-Montejano, R, Tapia, R, Jordan, I, Ferrer, R




Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer <i>Safety Run</i>-<i>in Results of the PENELOPE Trial</i>

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
González-Martín, A, Pautier, P, Mahner, S, Rau, J, Colombo, N, Ottevanger, P, del Campo, JM, Selle, F, du Bois, A, Gadducci, A, García, Y, Berton-Rigaud, D, Marmé, F, Ortega, E, Martin, N, Bastiere-Truchot, L, Kiermaier, A, Kurzeder, C

Objective: In platinum-resistant ovarian cancer, adding pertuzumab to gemcitabine improved progression-free survival in the subgroup with low tumor HER3 messenger RNA expression. The 2-part PENELOPE trial (NCT01684878) is prospectively investigating pertuzumab plus chemotherapy in this population. Patients and Methods: Part 1 evaluated pertuzumab plus either topotecan or paclitaxel. Patients with platinum-refractory or platinum-resistant recurrent ovarian, primary peritoneal, or fallopian tube...



Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
González-Martín, A, Alba, E, Ciruelos, E, Cortés, J, Llombart, A, Lluch, A, Andrés, R, Alvarez, I, Aramenda, JM, de la Peña, FA, Barnadas, A, Batista, N, Calvo, L, Galve, E, García-Palomo, A, García-Sáenz, JA, de la Haba, J, López, R, López-Vivanco, G, Martínez-Jáñez, N, de Dueñas, EM, Plazaola, A, Rodríguez-Lescure, A, Ruiz, M, Sánchez-Rovira, P, Santaballa, A, Seguí, MA, Tusquets, I, Zamora, P, Martín, M

Around 40% of patients with breast cancer will present with a recurrence of the disease. Chemotherapy is recommended for patients with recurrent hormone-independent or hormone-refractory breast cancer and almost all patients with metastatic breast cancer (MBC) receive chemotherapy during their medical history. Nanoparticle albumin-bound (nab)-paclitaxel is a solvent-free, 130-nanometer particle formulation of paclitaxel. Nab-paclitaxel can be administered to all patients for whom the treatment...



Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Jiménez-Fonseca, P, Carmona-Bayonas, A, Lorenzo, MLS, Plazas, JG, Custodio, A, Hernández, R, Garrido, M, García, T, Echavarría, I, Cano, JM, Palomo, AR, Mangas, M, Declara, IM, Ramchandani, A, Visa, L, Viudez, A, Buxó, E, Díaz-Serrano, A, López, C, Azkarate, A, Longo, F, Castañón, E, Bayona, RS, Pimentel, P, Limón, ML, Cerdá, P, Llosa, RA, Serrano, R, Lobera, MPF, Alsina, M, Nuño, A, Gómez-Martin, C

Trastuzumab significantly improves overall survival (OS) when added to cisplatin and fluoropyrimidine as a treatment for HER2-positive advanced gastric cancers (AGC). The aim of this study was to evaluate the impact of the gradual implementation of HER2 testing on patient prognosis in a national registry of AGC. This Spanish National Cancer Registry includes cases who were consecutively recruited at 28 centers from January 2008 to January 2016. The effect of missing HER2 status was assessed...



High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Mariño, Z, Pascasio-Acevedo, JM, Gallego, A, Diago, M, Baliellas, C, Morillas, R, Prieto, M, Moreno, JM, Sánchez-Antolín, G, Vergara, M, Forné, M, Fernández, I, Castro, MA, Pascual, S, Gómez, A, Castells, L, Montero, JL, Crespo, J, Calleja, JL, García-Samaniego, J, Carrión, JA, Arencibia, AC, Blasco, A, López-Núñez, C, Sánchez-Ruano, JJ, Gea-Rodríguez, F, Giráldez, A, Cabezas, J, Hontangas, V, Torras, X, Castellote, J, Romero-Gómez, M, Turnes, J, de Artaza, T, Narváez, I, Cuervas-Mons, V, Forns, X

Background and Aims: Hepatitis C (HCV) therapy with Sofosbuvir (SOF)/Simeprevir (SMV) in clinical trials and real-world clinical practice, showed high rates of sustained virological response (SVR) in non-cirrhotic genotype (GT)-1 and GT-4 patients. These results were slightly lower in cirrhotic patients. We investigated real-life effectiveness and safety of SOF/SMV with or without ribavirin (RBV) in a large cohort of cirrhotic patients. Methods: This collaborative multicentre study included...



Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Lainez, N, García-Donas, J, Esteban, E, Puente, J, Sáez, MI, Gallardo, E, Pinto-Marín, A, Vazquez-Estévez, S, León, L, García-Carbonero, I, Suárez-Rodríguez, C, Molins, C, Climent-Duran, MA, Lázaro-Quintela, M, del Alba, AG, Méndez-Vidal, MJ, Chirivella, I, Afonso, FJ, López-Brea, M, Sala-González, N, Domenech, M, Basterretxea, L, Santander-Lobera, C, Gil-Arnáiz, I, Fernández, O, Caballero-Díaz, C, Mellado, B, Marrupe, D, García-Sánchez, J, Sánchez-Escribano, R, Parra, EF, Guzmán, JCV, Martínez-Ortega, E, González, MB, Morán, M, Suarez-Paniagua, B, Lecumberri, MJ, Castellano, D

Background: The impact of such recommendations after their implementation of guidelines has not usually been evaluated. Herein, we assessed the impact and compliance with the Spanish Oncology Genitourinary Group (SOGUG) Guidelines for toxicity management of targeted therapies in metastatic renal cell carcinoma (mRCC) in daily clinical practice. Methods: Data on 407 mRCC patients who initiated first-line targeted therapy during the year before and the year after publication and implementation...



A home and ambulatory artificial nutrition (NADYA) Group Report, Home Parenteral Nutrition in Spain, 2013

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Wanden-Berghe, C, Compes, JCC, Peláez, RB, Candela, CG, Casas, NV, de la Cruz, AP, Villares, JMM, Pérez, FC, Orbaiz, CG, Faedo, CM, Lázaro, MAP, Marín, MG, Luna, PPG, Martín, PM, Paris, AS, Pérez, LML, Folgueras, TM, Zafra, MVG, Hernández, A, Martín, CC, Llanos, JPS, Zugasti, A, Celaya, AA, Planella, JRU, González, LL, Burdiel, OSV, Ortiz, CJ, Costa, CM, Casariego, AV, García, PL, González, MAP, Martínez, MCG, Martos, EAS, García, MDD, Guardiola, PD

Aim: to communicate the results of the Spanish Home Parenteral Nutrition (HPN) registry of the NADYA-SENPE group for the year 2013. Material and methods: data was recorded online by NADYA group collaborators that were responsible of the HPN follow-up from 1st January to 31st December 2013. Results: a total of 197 patients and 202 episodes of HPN were registered from 35 hospitals that represents a rate of 4,22 patients/million habitants/year 2013. The median age was 53 years (IQR 40 - 64) for...



GRECOS Project (Genotyping Recurrence Risk of Stroke) The Use of Genetics to Predict the Vascular Recurrence After Stroke

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Fernández-Cadenas, I, Mendióroz, M, Giralt, D, Nafria, C, Garcia, E, Carrera, C, Gallego-Fabrega, C, Domingues-Montanari, S, Delgado, P, Ribó, M, Castellanos, M, Martínez, S, Freijo, M, Jiménez-Conde, J, Rubiera, M, Alvarez-Sabín, J, Molina, CA, Font, MA, Olivares, MG, Palomeras, E, de la Ossa, NP, Martinez-Zabaleta, M, Masjuan, J, Moniche, F, Canovas, D, Piñana, C, Purroy, F, Cocho, D, Navas, I, Tejero, C, Aymerich, N, Cullell, N, Muiño, E, Serena, J, Rubio, F, Davalos, A, Roquer, J, Arenillas, JF, Martí-Fábregas, J, Keene, K, Chen, WM, Worrall, B, Sale, M, Arboix, A, Krupinski, J, Montaner, J

Background and Purpose-Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack. Clinical scores do not predict the whole vascular recurrence risk; therefore, we aimed to find genetic variants associated with recurrence that might improve the clinical predictive models in IS. Methods-We analyzed 256 polymorphisms from 115 candidate genes in 3 patient cohorts comprising 4482 IS or transient ischemic attack patients. The...



Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Thomas, M, Ponce-Aix, S, Navarro, A, Riera-Knorrenschild, J, Schmidt, M, Wiegert, E, Kapp, K, Wittig, B, Mauri, C, Gómez, MD, Kollmeier, J, Sadjadian, P, Fröhling, KP, Huber, RM, Wolf, M, Pall, G, Surmont, V, Bosquee, L, Germonpré, P, Brückl, W, Grah, C, Herzmann, C, Leistner, R, Meyer, A, Müller, L, Schmalz, O, Scholz, C, Schröder, M, Serke, M, Wesseler, C, Brandts, C, Kopp, HG, Blau, W, Griesinger, F, Campelo, MRG, Garcia, YG, Perez, JMT

Background: The immune surveillance reactivator lefitolimod (MGN1703), a DNA-based TLR9 agonist, might foster innate and adaptive immune response and thus improve immune-mediated control of residual cancer disease. The IMPULSE phase II study evaluated the efficacy and safety of lefitolimod as maintenance treatment in extensive-stage small-cell lung cancer (ES-SCLC) after objective response to first-line chemotherapy, an indication with a high unmet medical need and stagnant treatment...



Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Casanova, C, Celli, BR, de-Torres, JP, Martínez-Gonzalez, C, Cosio, BG, Pinto-Plata, V, de Lucas-Ramos, P, Divo, M, Fuster, A, Peces-Barba, G, Calle-Rubio, M, Solanes, I, Aguero, R, Feu-Collado, N, Alfageme, I, De Diego, A, Romero, A, Balcells, E, Llunell, A, Galdiz, JB, Marin, M, Moreno, A, Cabrera, C, Golpe, R, Lacarcel, C, Soriano, JB, López-Campos, JL, Soler-Cataluña, JJ, Marin, JM

The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains controversial. To evaluate the prevalence and stability of a high level of blood eosinophils (>= 300 cells.mu L-1) and its relationship to outcomes, we determined blood eosinophils at baseline and over 2 years in 424 COPD patients (forced expiratory volume in 1 s (FEV1) 60% predicted) and 67 smokers without COPD from the CHAIN cohort, and in 308 COPD patients (FEV1 60% predicted) in the BODE cohort. We...



Suicidal Thoughts and Behaviors Among First-Year College Students: Results From the WMH-ICS Project

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Mortier, P, Auerbach, RP, Alonso, J, Bantjes, J, Benjet, C, Cuijpers, P, Ebert, DD, Green, JG, Hasking, P, Nock, MK, Pinder-Amaker, S, Sampson, NA, Vilagut, G, Zaslaysky, AM, Bruffaerts, R, Kessler, RC, Boyes, M, Kiekens, G, Baumeister, H, Kaehlke, F, Berking, M, Ramírez, AA, Borges, G, Diaz, AC, Duran, MS, Gonzalez, RG, Gutierrez-Garcia, RA, de la Torre, AEH, Martinez, KIM, Medina-Mora, ME, Zarazua, HM, Tarango, GP, Berbena, MAZ, O'Neill, S, Bjourson, T, Lochner, C, Roos, J, Cur, HB, Taljaard, L, Saal, W, Stein, D, Alayo, I, Almenara, J, Ballester, L, Barbaglia, G, Blasco, MJ, Castellvi, P, Cebria, AI, Echeburua, E, Gabilondo, A, Garcia-Forero, C, Iruin, A, Lagares, C, Miranda-Mendizabal, A, Pares-Badell, O, Perez-Vazquez, MT, Piqueras, JA, Roca, M, Rodriguez-Marin, J, Gili, M, Soto-Sanz, V, Vives, M

Objective: College entrance may be a strategically well-placed "point of capture" for detecting late adolescents with suicidal thoughts and behaviors (STB). However, a clear epidemiological picture of STB among incoming college students is lacking. We present the first cross-national data on prevalence as well as socio-demographic and college-related correlates for STB among first-year college students. Method: Web-based self-report surveys were obtained from 13,984 first-year...



The intensive care medicine research agenda for airways, invasive and noninvasive mechanical ventilation

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Jaber, S, Bellani, G, Blanch, L, Demoule, A, Esteban, A, Gattinoni, L, Guérin, C, Hill, N, Laffey, JG, Maggiore, SM, Mancebo, J, Mayo, PH, Mosier, JM, Navalesi, P, Quintel, M, Vincent, JL, Marini, JJ

In an important sense, support of the respiratory system has been a defining characteristic of intensive care since its inception. The pace of basic and clinical research in this field has escalated over the past two decades, resulting in palpable improvement at the bedside as measured by both efficacy and outcome. As in all medical research, however, novel ideas built upon observations are continually proposed, tested, and either retained or discarded on the basis of the persuasiveness of the...



Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
González-López, TJ, Pascual, C, Alvarez-Román, MT, Fernández-Fuertes, F, Sánchez-González, B, Caparros, I, Jarque, I, Mingot-Castellano, ME, Hernández-Rivas, JA, Martín-Salces, M, Solán, L, Beneit, P, Jiménez, R, Bernat, S, Andrade, MM, Cortés, M, Cortti, MJ, Pérez-Crespo, S, Gómez-Núñez, M, Olivera, PE, Pérez-Rus, G, Martínez-Robles, V, Alonso, R, Fernández-Rodríguez, A, Arratibel, MC, Perera, M, Fernández-Miñano, C, Fuertes-Palacio, MA, Vázquez-Paganini, JA, Gutierrez-Jomarron, I, Valcarce, I, de Cabo, E, Sainz, A, Fisac, R, Aguilar, C, Martínez-Badas, MP, Peñarrubia, MJ, Calbacho, M, de Cos, C, González-Silva, M, Coria, E, Alonso, A, Casaus, A, Luaña, A, Galán, P, Fernández-Canal, C, Garcia-Frade, J, González-Porras, JR

Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the frequency of this phenomenon is unknown. We retrospectively evaluated 260 adult primary ITP patients (165 women and 95 men; median age, 62 years) treated with eltrombopag after a median time from diagnosis of 24 months. Among the 201 patients who achieved a complete remission (platelet count >100 x 10(9)/l), eltrombopag was discontinued in...



Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Mauri, T, Yoshida, T, Bellani, G, Goligher, E, Carteaux, G, Rittayamai, N, Mojoli, F, Chiumello, D, Piquilloud, L, Grasso, S, Jubran, A, Laghi, F, Magder, S, Pesenti, A, Loring, S, Gattinoni, L, Talmor, D, Blanch, L, Amato, M, Chen, L, Brochard, L, Mancebo, J

Esophageal pressure (Pes) is a minimally invasive advanced respiratory monitoring method with the potential to guide management of ventilation support and enhance specific diagnoses in acute respiratory failure patients. To date, the use of Pes in the clinical setting is limited, and it is often seen as a research tool only. This is a review of the relevant technical, physiological and clinical details that support the clinical utility of Pes. After appropriately positioning of the esophageal...



Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Rúa-Figueroa, I, Richi, P, López-Longo, FJ, Galindo, M, Calvo-Alén, J, Olivé-Marqués, A, Loza-Santamaría, E, Vicente, SP, Erausquin, C, Tomero, E, Horcada, L, Uriarte, E, Sánchez-Atrio, A, Rosas, J, Montilla, C, Fernández-Nebro, A, Rodríguez-Gómez, M, Vela, P, Blanco, R, Freire, M, Silva, L, Díez-Alvarez, E, Ibáñez-Barceló, M, Zea, A, Narváez, J, Martínez-Taboada, V, Marenco, JL, de Castro, MF, Fernández-Berrizbeitia, O, Hernández-Beriain, JA, Gantes, M, Hernández-Cruz, B, Pérez-Venegas, JJ, Pecondón, A, Marras, C, Carreira, P, Bonilla, G, Torrente, V, Castellví, I, Alegre, J, Moreno, M, Raya, E, de la Peña, PG, Vázquez, T, Aguirre, A, Quevedo, V, Pego-Reigosa, JM

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvement and pronounced racial and ethnic heterogeneity. The aims of the present work were (1) to describe the cumulative clinical characteristics of those patients included in the Spanish Rheumatology Society SLE Registry (RELESSER), focusing on the differences between patients who fulfilled the 1997 ACR-SLE criteria versus those with less than 4 criteria (hereafter designated as incomplete SLE (iSLE...



WHO World Mental Health Surveys International College Student Project: Prevalence and Distribution of Mental Disorders

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Auerbach, RP, Mortier, P, Bruffaerts, R, Alonso, J, Benjet, C, Cuijpers, P, Demyttenaere, K, Ebert, DD, Green, JG, Hasking, P, Murray, E, Nock, MK, Pinder-Amaker, S, Sampson, NA, Stein, DJ, Vilagut, G, Zaslavsky, AM, Kessler, RC, Boyes, M, Kiekens, G, Baumeister, H, Kaehlke, F, Berking, M, Ramírez, AA, Borges, G, Díaz, AC, Durán, MS, González, R, Gutiérrez-García, RA, de la Torre, AEH, Martínez, KIM, Medina-Mora, ME, Zarazúa, HM, Tarango, GP, Berbena, MAZ, O'Neill, S, Bjourson, T, Lochner, C, Roos, J, Taljaard, L, Bantjes, J, Saal, W, Alayo, I, Almenara, J, Ballester, L, Barbaglia, G, Blasco, MJ, Castellví, P, Cebriá, AI, Echeburúa, E, Gabilondo, A, García-Forero, C, Iruin, A, Lagares, C, Miranda-Mendizábal, A, Pares-Badell, O, Perez-Vazquez, MT, Piqueras, JA, Roca, M, Rodríguez-Marín, J, Gili, M, Soto-Sanz, V, Vives, M

Increasingly, colleges across the world are contending with rising rates of mental disorders, and in many cases, the demand for services on campus far exceeds the available resources. The present study reports initial results from the first stage of the WHO World Mental Health International College Student project, in which a series of surveys in 19 colleges across 8 countries (Australia, Belgium, Germany, Mexico, Northern Ireland, South Africa, Spain, United States) were carried out with the...



Severe role impairment associated with mental disorders: Results of the WHO World Mental Health Surveys International College Student Project

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Alonso, J, Mortier, P, Auerbach, RP, Bruffaerts, R, Vilagut, G, Cuijpers, P, Demyttenaere, K, Ebert, DD, Ennis, E, Green, JG, Hasking, P, Nock, MK, Pinder-Amaker, S, Sampson, NA, Zaslavsky, AM, Kessler, RC, Boyes, M, Kiekens, G, Baumeister, H, Kaehlke, F, Berking, M, Ramírez, AA, Benjet, C, Borges, G, Díaz, AC, Durán, MS, González, RG, Gutiérrez-García, RA, de la Torre, AEH, Martínez, KIM, Medina-Mora, ME, Zarazúa, HM, Tarango, GP, Berbena, MAZ, O'Neill, S, Bjourson, T, Lochner, C, Saal, W, Stein, D, Almenara, J, Ballester, L, Barbaglia, G, Blasco, MJ, Castellví, P, Cebrià, AI, Echeburúa, E, Gabilondo, A, García-Forero, C, Iruin, A, Lagares, C, Miranda-Mendizábal, A, Parès-Badell, O, Pérez-Vázquez, MT, Piqueras, JA, Roca, M, Rodríguez-Marín, J, Gili, M, Soto-Sanz, V, Vives, M, Alayo, I, Roos, J, Taljaard, L

Background: College entrance is a stressful period with a high prevalence of mental disorders. Aims: To assess the role impairment associated with 12-month mental disorders among incoming first-year college students within a large cross-national sample. Methods: Web-based self-report surveys assessing the prevalence of DSM-IV mental disorders and health-related role impairment (Sheehan Disability Scale) were obtained and analyzed from 13,984 incoming first-year college students (Response = 45...



HOME AND AMBULATORY ARTIFICIAL NUTRITION (NADYA) GROUP REPORT, HOME PARENTERAL NUTRITION IN SPAIN, 2014

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Wanden-Berghe, C, Cunill, JLP, Compes, CC, Villares, JMM, de la Cruz, AP, Peláez, RB, Candela, CG, Casas, NV, Lázaro, MAP, Faedo, CM, Orbaiz, CG, Marín, MG, Paris, AS, Alvarez, J, Martos, EAS, Folgueras, TM, Martín, CC, Martín, PM, Zugasti, A, Pérez, FC, Zafra, MVG, González, MAP, Llanos, JPS, Costa, CM, de Luis, D, Celaya, AA, Pérez, LML, Guardiola, PD, Martínez, MCG, García, MDD, Grupo, PLG, Casariego, AV, Ortiz, CJ, Burdiel, OSV, González, LL

Aim: to communicate the results of the Spanish Home Parenteral Nutrition (HEN) registry of the NADYA-SENPE group for the year 2014. Material and methods: data was recorded online by NADYA group collaborators that were responsible of the HPN follow-up from 1st January to 31st December 2014. Results: a total of 220 patients and 229 episodes of HPN were registered from 37 hospitals that represents a rate of 4.7 patients/million habitants/year 2014. The most frequent disease in adults was other...



A deletion at <i>ADAMTS9</i>-<i>MAGI1</i> locus is associated with psoriatic arthritis risk

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Julià, A, Pinto, JA, Gratacós, J, Queiró, R, Ferrándiz, C, Fonseca, E, Montilla, C, Torre-Alonso, JC, Puig, L, Venegas, JJP, Nebro, AF, Fernández, E, Muñoz-Fernández, S, Daudén, E, González, C, Roig, D, Carazo, JLS, Zarco, P, Erra, A, Estebaranz, JLL, Rodríguez, J, Ramírez, DM, de la Cueva, P, Vanaclocha, F, Herrera, E, Castañeda, S, Rubio, E, Salvador, G, Díaz-Torné, C, Blanco, R, Domínguez, AW, Mosquera, JA, Vela, P, Tornero, J, Sánchez-Fernández, S, Corominas, H, Ramírez, J, López-Lasanta, M, Tortosa, R, Palau, N, Alonso, A, García-Montero, AC, Gelpí, JL, Codó, L, Day, K, Absher, D, Myers, RM, Cañete, JD, Marsal, S

Objective Copy number variants (CNVs) have been associated with the risk to develop multiple autoimmune diseases. Our objective was to identify CNVs associated with the risk to develop psoriatic arthritis (PsA) using a genome-wide analysis approach. Methods A total of 835 patients with PsA and 1498 healthy controls were genotyped for CNVs using the Illumina HumanHap610 BeadChip genotyping platform. Genomic CNVs were characterised using CNstream analysis software and analysed for association...



Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Lodi, S, Costagliola, D, Sabin, C, del Amo, J, Logan, R, Abgrall, S, Reiss, P, van Sighem, A, Jose, S, Blanco, JR, Hernando, V, Bucher, HC, Kovari, H, Segura, F, Ambrosioni, J, Gogos, CA, Pantazis, N, Dabis, F, Vandenhende, MA, Meyer, L, Seng, R, Gill, MJ, Krentz, H, Phillips, AN, Porter, K, Grinsztejn, B, Pacheco, AG, Muga, R, Tate, J, Justice, A, Hernán, MA

Background: Clinical guidelines recommend immediate initiation of combined antiretroviral therapy for all HV-positive individuals. However, those guidelines are based on trials of relatively young participants. Methods: We included HIV-positive antiretroviral therapy-naive, AIDS-free individuals aged 50-70 years after 2004 in the HIV-CAUSAL Collaboration. We used the parametric g-formula to estimate the 5-year risk of all-cause and non-AIDS mortality under (1) immediate initiation at baseline...



Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Chereau, F, Madec, Y, Sabina, C, Obel, N, Ruiz-Mateos, E, Chrysos, G, Fidler, S, Lehmann, C, Zangerle, R, Wittkop, L, Reiss, P, Hamouda, O, Perez, VE, Leal, M, Mocroft, A, De Olalla, PG, Ammassari, A, Monforte, AD, Mussini, C, Segura, F, Castagna, A, Cavassini, M, Grabar, S, Morlat, P, De Wit, S, Lambotte, O, Meyer, L

Objective HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. The objective was to identify factors associated with loss of virological control. Methods HICs were identified in COHERE on the basis of >= 5 consecutive viral loads (VL) <= 500 copies/mL over >= 1 year whilst ART-naive, with the last VL <= 500 copies/mL measured >= 5...



Home and Ambulatory Artificial Nutrition (NADYA) Report. Home Parenteral Nutrition in Spain, 2017

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Wanden-Berghe, C, Cunill, JLP, Compes, CC, Boluda, ER, Jiménez, MIM, Candela, CG, Casas, NV, Peláez, RB, de la Cruz, AP, Lázaro, MAP, Martos, EAS, Roman, DAD, Faedo, CM, Fontalba, MDM, Hernández, JA, Martín, PM, Guardiola, PD, Pérez, FC, París, AS, Orbaiz, CG, Burdiel, OSV, Folgueras, TM, Palmero, MAM, Pérez, LML, Murillo, AZ, Costa, CM, Llanos, JPS, Pérez, CT, Rocamora, JAI, Irigoyen, CA, Delgado, YG, Martín, CC, González, MAP, Roca, SM, Zafra, MVG, López, JMM, Baeza, BM, Marín, MG, Ortiz, CJ, de la Maza, BP, Martínez, MCG, Santaliestra, MJC, Visa, MDF, Celaya, AA, Sánchez, RS, Planella, JRU

Aim: to communicate HPN data obtained from the HPN registry of the NADYA-SENPE group (www.nadya-senpe.com) for the year 2017. Material and methods: descriptive analysis of the data collected from adult and pediatric patients with HPN in the NADYA-SENPE group registry from January 1st, 2017 to December 31st, 2017. Results: there were 308 patients from 45 Spanish hospitals (54.5% women), 38 children and 270 adults, with 3,012 episodes, which represent a prevalence rate of 6.61 patients/million...



Home and Ambulatory Artiificial Nutrition (NADYA) Group Report - Home parenteral nutrition in Spain, 2016

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Wanden-Berghe, C, Casas, NV, Boluda, ER, Compes, CC, Villares, JMM, Cunill, JLP, Candela, CG, Peláez, RB, Lázaro, MAP, de la Cruz, AP, Hernández, JA, Marín, MG, Martín, PM, Faedo, CM, Martos, EAS, Parisi, AS, Martín, CC, Folgueras, TM, Palmero, MAM, Fontalba, MDM, Pérez, LML, Murillo, AZ, Ramírez, MJM, Pérez, FC, Costa, CM, Guardiola, PD, Pérez, CT, Marimon, RMP, Rocamora, JAI, Orbaiz, CG, González, MAP, Zafra, MVG, Sánchez, RS, Planella, JRU, Celaya, AA, Burdiel, OSV, Ortiz, CJ, Lianas, JPS, de la Maza, BP, García, PL, Martínez, MCG, Roca, SM, Santaliestra, MJC

Objective: To communicate HPN data obtained from the HPN registry of the NADYA-SENPE group (www.nadya-senpe.com) for the year 2016. Material and methods: Descriptive analysis of the data collected from adult and pediatric patients with HPN in the NADYA-SENPE group registry from January 1st, 2016 to December 31st, 2016. Results: There were 286 patients from 42 Spanish hospitals (54.2% women), 34 children and 252 adults, with 294 episodes, which represent a prevalence rate of 6.16 patients /...



Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk A Meta-analytical Stratification

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Fusar-Poli, P, Cappucciati, M, Borgwardt, S, Woods, SW, Addington, J, Nelson, B, Nieman, DH, Stahl, DR, Rutigliano, G, Riecher-Rössler, A, Simon, AE, Mizuno, M, Lee, TY, Kwon, JS, Lam, ML, Perez, J, Keri, S, Amminger, P, Metzler, S, Kawohl, W, Rössler, W, Lee, J, Labad, J, Ziermans, T, An, SK, Liu, CC, Woodberry, KA, Braham, A, Corcoran, C, McGorry, P, Yung, AR, McGuire, PK

IMPORTANCE Individuals can be classified as being at clinical high risk (CHR) for psychosis if they meet at least one of the ultra-high-risk (UHR) inclusion criteria (brief limited intermittent psychotic symptoms [BLIPS] and/or attenuated psychotic symptoms [APS] and/or genetic risk and deterioration syndrome [GRD]) and/or basic symptoms [BS]. The meta-analytical risk of psychosis of these different subgroups is still unknown. OBJECTIVE To compare the risk of psychosis in CHR individuals who...



Home Parenteral Nutrition in Spain, 2015. Home and Ambulatory Artificial Nutrition (NADYA) Group report

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Wanden-Berghe, C, Martín, CC, Compes, CC, Candela, CG, Peláez, RB, Villares, JMM, Cunill, JLP, de la Cruz, AP, Casas, NV, Faedo, CM, Hernandez, JA, Orbaiz, CG, Lázaro, MA, Martos, EAS, Paris, AS, Marín, MG, Murillo, AZ, Martín, PM, Folgueras, TM, Pérez, FC, Guardiola, PD, Pérez, CT, Román, DD, Pérez, LML, Carmona, NS, Celaya, AA, González, MAP, Planella, JRU, González, LL, Olmos, MAM, Burdiel, OSV, Ortiz, CJ, Costa, CM, Llanos, JPS, Fernández, AC, García, PL, Martínez, MCG, Mauri, S, Zafra, MVG, Santaliestra, MJC

Aim: To communicate the results of the Spanish Home Parenteral Nutrition (HEN) registry of the NADYA-SENPE group for the year 2015. Material and methods: Data was recorded online by NADYA group collaborators that were responsible of the HPN follow-up from 1st January to 31st December 2015. Results: Two hundred and thirty-six patients with 243 episodes of NPD were recorded from 40 hospitals. This represents a rate of 5.08 patients/million habitants for 2015. The most frequent pathology in...



Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Palacios-Baena, ZR, Gutiérrez-Gutiérrez, B, Calbo, E, Almirante, B, Viale, P, Oliver, A, Pintado, V, Gasch, O, Martínez-Martínez, L, Pitout, J, Akova, M, Peña, C, Gil-Bermejo, JM, Hernández, A, Venditti, M, Prim, N, Bou, G, Tacconelli, E, Tumbarello, M, Hamprecht, A, Giamarellou, H, Almela, M, Pérez, F, Schwaber, MJ, Bermejo, J, Lowman, W, Hsueh, PR, Paño-Pardo, JR, Torre-Cisneros, J, Souli, M, Bonomo, RA, Carmeli, Y, Paterson, DL, Pascual, A, Rodríguez-Baño, J

Background. There is little information about the efficacy of active alternative drugs to carbapenems except beta-lactam/beta-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). The objective of this study was to assess the outcomes of patients with BSI due to ESBL-E who received empiric therapy with such drugs (other active drugs [OADs]) or carbapenems. Methods. A multinational retrospective...



Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- ß-lactamase-producing Enterobacteriaceae

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Palacios-Baena, ZR, Gutiérrez-Gutiérrez, B, De Cueto, M, Viale, P, Venditti, M, Hernández-Torres, A, Oliver, A, Martínez-Martínez, L, Calbo, E, Pintado, V, Gasch, O, Almirante, B, Lepe, JA, Pitout, J, Akova, M, Peña-Miralles, C, Schwaber, MJ, Tumbarello, M, Tacconelli, E, Origüen, J, Prim, N, Bou, G, Giamarellou, H, Bermejo, J, Hamprecht, A, Pérez, F, Almela, M, Lowman, W, Hsueh, PR, Francisco, CNS, Torre-Cisneros, J, Carmeli, Y, Bonomo, RA, Paterson, DL, Pascual, A, Rodríguez-Baño, J

Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality. Methods. A multinational retrospective cohort study including consecutive episodes of BSI due to ESBL-E was performed; cases were randomly assigned to a derivation cohort (DC) or a validation cohort (VC). The main outcome variable was...



Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study

Repositorio: r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Gutiérrez-Gutiérrez, B, Bonomo, RA, Carmeli, Y, Paterson, DL, Almirante, B, Martínez-Martínez, L, Oliver, A, Calbo, E, Peña, C, Akova, M, Pitout, J, Origüen, J, Pintado, V, García-Vázquez, E, Gasch, O, Hamprecht, A, Prim, N, Tumbarello, M, Bou, G, Viale, P, Tacconelli, E, Almela, M, Pérez, F, Giamarellou, H, Cisneros, JM, Schwaber, MJ, Venditti, M, Lowman, W, Bermejo, J, Hsueh, PR, Mora-Rillo, M, Gracia-Ahulfinger, I, Pascual, A, Rodríguez-Baño, J

Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other carbapenems in monomicrobial BSI due to ESBL-E. Methods: A multinational retrospective cohort study (INCREMENT project) was performed (ClinicalTrials.gov identifier: NCT01764490). Patients given monotherapy with ertapenem or other carbapenems were compared. Empirical and...